RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Eloxx Pharmaceuticals Stock

Eloxx Pharmaceuticals ROCE 2024

Eloxx Pharmaceuticals ROCE

3.23

Ticker

ELOX

ISIN

US29014R1032

WKN

A2JAHU

In 2024, Eloxx Pharmaceuticals's return on capital employed (ROCE) was 3.23, a -209.48% increase from the -2.95 ROCE in the previous year.

Eloxx Pharmaceuticals Aktienanalyse

What does Eloxx Pharmaceuticals do?

Eloxx Pharmaceuticals was founded in Israel in 2013 and is headquartered in Waltham, Massachusetts, USA. The company is a rising biopharmaceutical company focused on developing innovative therapies for rare and severe diseases. With its innovative approach in the field of precision medicine, Eloxx aims to give new impetus to the research and development of therapies for patients struggling with rare diseases. Eloxx's business model is based on improving or restoring the translational reading ability of defective messenger RNA (mRNA) into functional protein production. This technology platform has the potential to deliver therapeutic candidates for a variety of diseases with limited or no treatment options. In the field of clinical development, Eloxx focuses on developing drugs for rare genetic diseases such as cystic fibrosis and nonsense mutations in ophthalmoplegia, cellular and musculoskeletal diseases, as well as central nervous system disorders. One of Eloxx's main products is ELX-02, a nucleotide-modified RNA therapy targeting the treatment of cystic fibrosis. The therapy specifically aims to treat defects caused by nonsense mutations in patients who have an intact gene copy but lack a functional protein in their airways. As such a nonsense mutation stops the information on an RNA sequence before the complete protein could be produced, ELX-02 acts modulating on RNA degradation mechanisms and thus increases the rate of protein production by restoring the remaining genuine sequence. Furthermore, Eloxx's technology platform offers the potential for the development of novel drugs targeting unexplored diseases. The company addresses this potential through close collaboration with institutions, including patient groups and a variety of research and development organizations, to develop new drugs and therapies. Eloxx also considers strategic alliances and partnerships to increase the availability of its therapies, promote the use of RNA therapies in rare diseases, and therefore provide better treatment options for owners of rare disease cycles. Additionally, the company also offers patent protection and licenses for its technologies and products. In summary, Eloxx Pharmaceuticals is a globally operating company focused on researching and developing therapies for rare and severe diseases. The company relies on an innovative technology platform to solve the problem of nonsense mutations in mRNA and provide RNA-based precision medicine for the first time. Eloxx aims to establish a solid foundation for the development of novel therapies and drugs to unlock the full potential of RNA therapy in the treatment of rare diseases. Eloxx Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Eloxx Pharmaceuticals's Return on Capital Employed (ROCE)

Eloxx Pharmaceuticals's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Eloxx Pharmaceuticals's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Eloxx Pharmaceuticals's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Eloxx Pharmaceuticals’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Eloxx Pharmaceuticals stock

What is the ROCE (Return on Capital Employed) of Eloxx Pharmaceuticals this year?

The ROCE of Eloxx Pharmaceuticals is 3.23 undefined this year.

How has the ROCE (Return on Capital Employed) of Eloxx Pharmaceuticals developed compared to the previous year?

The ROCE of Eloxx Pharmaceuticals has increased by -209.48% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Eloxx Pharmaceuticals?

A high Return on Capital Employed (ROCE) indicates that Eloxx Pharmaceuticals has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Eloxx Pharmaceuticals?

A low ROCE (Return on Capital Employed) can indicate that Eloxx Pharmaceuticals has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Eloxx Pharmaceuticals impact the company?

An increase in the ROCE of Eloxx Pharmaceuticals can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Eloxx Pharmaceuticals affect the company?

A decrease in ROCE of Eloxx Pharmaceuticals can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Eloxx Pharmaceuticals?

Some factors that can affect Eloxx Pharmaceuticals's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Eloxx Pharmaceuticals so important for investors?

The ROCE of Eloxx Pharmaceuticals is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Eloxx Pharmaceuticals take to improve the ROCE?

To improve the ROCE, Eloxx Pharmaceuticals can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Eloxx Pharmaceuticals pay?

Over the past 12 months, Eloxx Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Eloxx Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Eloxx Pharmaceuticals?

The current dividend yield of Eloxx Pharmaceuticals is .

When does Eloxx Pharmaceuticals pay dividends?

Eloxx Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Eloxx Pharmaceuticals?

Eloxx Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Eloxx Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Eloxx Pharmaceuticals located?

Eloxx Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Eloxx Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Eloxx Pharmaceuticals from 9/27/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Eloxx Pharmaceuticals pay the last dividend?

The last dividend was paid out on 9/27/2024.

What was the dividend of Eloxx Pharmaceuticals in the year 2023?

In the year 2023, Eloxx Pharmaceuticals distributed 0 USD as dividends.

In which currency does Eloxx Pharmaceuticals pay out the dividend?

The dividends of Eloxx Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Eloxx Pharmaceuticals

Our stock analysis for Eloxx Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Eloxx Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.